MENS
Jyong Biotech Ltd. Ordinary Shares
1W: -14.1%
1M: -14.6%
3M: -41.8%
YTD: -50.1%
$1.70
-0.09 (-5.03%)
After Hours: $1.60 (-0.10, -5.88%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$129.2M
52W Range1.43-67
Volume191,251
Avg Volume885,783
Beta6.19
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOFu-Feng Kuo
Employees31
SectorHealthcare
IndustryBiotechnology
IPO Date2025-06-17
Websitejyongbio.com/
23F‑3, No. 95, Section 1, Xintai 5th Road
New Taipei City 221
TW
New Taipei City 221
TW
886 2 2732 5205
About Jyong Biotech Ltd. Ordinary Shares
Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages
Recent Insider Trades
No insider trades found